Sandra Montesino and two others are out at Daniel’s Table as the non-profit's co-founder is set to take the reins, again. Montesino, the now-former executive director of the Framingham nonprofit, ...

Community driven content discussing all aspects of software development from DevOps to design patterns. While social media websites such Facebook and LinkedIn made it incredibly easy for a user to ...

Small Table, Floor Mattress: Inside The Cell Of South Korea's Ex-First Lady Kim Keon Hee's solitary cell has a small table that can be used as a desk and for eating meals and a floor mattress to sleep ...

A major accident involving multiple vehicles, including two 18-wheelers, shut down Interstate 10 near Cardinal Drive late Thursday night. Beaumont police responded to the crash at approximately 10:41 ...

Cell membranes protect and organize cells. All cells have an outer plasma membrane that regulates not only what enters the cell, but also how much of any given substance comes in. Unlike prokaryotes, ...

Australian biotech Mesoblast can go ahead with a US filing for its off-the-shelf stem cell therapy for acute graft-versus-host disease (GVHD), after negotiations with the FDA. The ‘rolling’ biologics ...

Uncover the rich cultures and stories of First Nations peoples that were disrupted and displaced by settlement on goldfields. Unearth extraordinary stories of people who came to this country to try – ...

TAMPA, Fla. - Tampa man, Jose Pabon, has been sentenced to more than 21 years in federal prison for his role in a large-scale cocaine distribution conspiracy. The sentencing, handed down by U.S.

A 1099 form is used to report forms of non-employment income to the Internal Revenue Service (IRS). Businesses are typically required to issue a 1099 form to a taxpayer other than a corporation who ...

A West Palm Beach man who was already sentenced to 47 years in prison for a home invasion robbery scheme was sentenced to nearly seven additional years for assaulting a witness who testified against ...

BOSTON--(BUSINESS WIRE)--Kelonia Therapeutics, Inc., a biotech company revolutionizing in vivo gene delivery, today announced that the first patient has been dosed in the inMMyCAR study, a Phase 1 ...